Author name: mikeatshd

Can Diabetes Care Teams Improve Patient Outcomes and Value?

Can Diabetes Care Teams Improve Patient Outcomes and Value?

David G. Armstrong, DPM, MD, PhD; Gary M. Rothenberg, DPM, CDCES, CWS DISCLOSURES | October 18, 2024 What if teams of specialists from primary care, podiatry, endocrinology, infectious disease, vascular surgery, behavioral health, and other disciplines as needed routinely met as a “limb preservation board” or a “high-risk limb board” to discuss their shared patients, identify risks, […]

Can Diabetes Care Teams Improve Patient Outcomes and Value? Read More »

Podimetrics Finds 65% of Medicaid Patients with Type 2 Diabetes Struggle with Mental Health, Seek More Remote Care Support

Podimetrics Finds 65% of Medicaid Patients with Type 2 Diabetes Struggle with Mental Health, Seek More Remote Care Support

Podimetrics’ survey of 1,001 Medicaid beneficiaries with type 2 diabetes reveals that 65% face chronic behavioral health challenges, impacting their diabetes care. Depression and anxiety disrupt medication adherence and more. Findings highlight the urgent need for integrated mental and physical health support and demand for innovative tools.

Podimetrics Finds 65% of Medicaid Patients with Type 2 Diabetes Struggle with Mental Health, Seek More Remote Care Support Read More »

Podcast: Revolutionizing Diabetes Care – A Conversation with Podimetrics CEO and Co-founder Jon Bloom

Podcast: Revolutionizing Diabetes Care – A Conversation with Podimetrics CEO and Co-founder Jon Bloom

In this episode of Becker’s Healthcare Podcast, Jon Bloom, CEO and co-founder of Podimetrics, shares how technology is transforming diabetes care. He highlights the vital role of patient engagement and adherence, the challenges of managing diabetes in underserved populations, and Podimetrics’ innovative solutions to improve outcomes for patients, payers, and providers.

Podcast: Revolutionizing Diabetes Care – A Conversation with Podimetrics CEO and Co-founder Jon Bloom Read More »

Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test

San Diego, CA, July 31, 2024 (GLOBE NEWSWIRE) — Mindera Health Inc. announces the closing of a $14M convertible note financing, led by Mountain Group Partners and other existing investors in anticipation of a Series B financing in 2025. Proceeds will support the continued commercialization of Mindera’s lead product, Mind.Px™. “This capital raise will fuel

Mindera Health Secures $14 Million to Advance Commercialization of First and Only Psoriasis Precision Medicine Test Read More »